139 related articles for article (PubMed ID: 37924487)
1. Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances.
Mou X; Peng Z; Yin T; Sun X
J Gastrointest Cancer; 2024 Mar; 55(1):118-128. PubMed ID: 37924487
[TBL] [Abstract][Full Text] [Related]
2. Blood-based biomarkers for early detection of esophageal squamous cell carcinoma.
Chu LY; Peng YH; Weng XF; Xie JJ; Xu YW
World J Gastroenterol; 2020 Apr; 26(15):1708-1725. PubMed ID: 32351288
[TBL] [Abstract][Full Text] [Related]
3. Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.
Zhao YX; Zhao HP; Zhao MY; Yu Y; Qi X; Wang JH; Lv J
World J Gastroenterol; 2024 May; 30(20):2638-2656. PubMed ID: 38855150
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy of oesophageal squamous cell carcinoma: implications in diagnosis, prognosis, and treatment monitoring.
Hao MJ; Cheng ZY; Gao Y; Xin L; Yu CT; Wang TL; Li ZS; Wang LW
Scand J Gastroenterol; 2024 Jun; 59(6):698-709. PubMed ID: 38466190
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma.
Xu YW; Peng YH; Xu LY; Xie JJ; Li EM
World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma.
Sun G; Ye H; Wang X; Li T; Jiang D; Qiu C; Dai L; Shi J; Wang K; Song C; Wang P; Zhang J
Cancer Med; 2020 Feb; 9(3):1173-1182. PubMed ID: 31856412
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China.
Gao Y; Xin L; Feng YD; Yao B; Lin H; Sun C; An W; Li ZS; Shi RH; Wang LW
Am J Gastroenterol; 2021 Nov; 116(11):2207-2215. PubMed ID: 34546186
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update.
Liu F; Tian T; Xia LL; Ding Y; Cormier RT; He Y
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27003597
[TBL] [Abstract][Full Text] [Related]
10. MAEL as a diagnostic marker for the early detection of esophageal squamous cell carcinoma.
Abbaszadegan MR; Taghehchian N; Aarabi A; Akbari F; Saburi E; Moghbeli M
Diagn Pathol; 2021 Apr; 16(1):36. PubMed ID: 33902648
[TBL] [Abstract][Full Text] [Related]
11. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
Chen W; Li H; Ren J; Zheng R; Shi J; Li J; Cao M; Sun D; He S; Sun X; Cao X; Feng S; Zhou J; Luo P; Zha Z; Jia S; Wang J; Ma H; Zeng H; Canfell K; He J
Int J Cancer; 2021 Jan; 148(2):329-339. PubMed ID: 32663318
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma.
Yang L; Salai A; Sun X; Liu Q; Liu T; Zhang Q; Tuerxun A; Tan Y; Zheng S; Lu X
J Proteomics; 2022 Aug; 265():104662. PubMed ID: 35728771
[TBL] [Abstract][Full Text] [Related]
14. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China.
Li H; Ding C; Zeng H; Zheng R; Cao M; Ren J; Shi J; Sun D; He S; Yang Z; Yu Y; Zhang Z; Sun X; Guo G; Song G; Wei W; Chen W; He J
Cancer Commun (Lond); 2021 Aug; 41(8):715-725. PubMed ID: 34146456
[TBL] [Abstract][Full Text] [Related]
15. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.
di Pietro M; Canto MI; Fitzgerald RC
Gastroenterology; 2018 Jan; 154(2):421-436. PubMed ID: 28778650
[TBL] [Abstract][Full Text] [Related]
17. A novel rapid quantitative method reveals stathmin-1 as a promising marker for esophageal squamous cell carcinoma.
Yan L; Dong X; Gao J; Liu F; Zhou L; Sun Y; Zhao X
Cancer Med; 2018 May; 7(5):1802-1813. PubMed ID: 29577639
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
[TBL] [Abstract][Full Text] [Related]
19. A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma.
Lv J; Wang J; Shen X; Liu J; Zhao D; Wei M; Li X; Fan B; Sun Y; Xue F; Zhu ZJ; Zhang T
Clin Transl Med; 2021 May; 11(5):e419. PubMed ID: 34047482
[No Abstract] [Full Text] [Related]
20. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma.
Zhao J; Zhao X; Yu J; Gao S; Zhang M; Yang T; Liu L
Anal Chim Acta; 2022 Aug; 1220():340038. PubMed ID: 35868700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
